Study Design, An animal model of laminectomy in rats was used to study
scar tissue formation around the spinal cord, Dexamethasone, in contr
olled-release form, was tested in this system for its ability to decre
ase fibrous tissue formation. Objectives, The results were evaluated t
o determine whether dexamethasone in a biodegradable controlled-releas
e vehicle could be used to limit scar tissue formation around the spin
al cord after laminectomy. Summary of Background Data. Steroids can de
lay the formation of scar tissue. Continued treatment with r=s dexamet
hasone results in various unacceptable side effects. Use of biodegrada
ble controlled-release vehicles to deliver drugs may allow for prolong
ed low-dose treatment, concentrated at the surgical site, thereby avoi
ding side effects. Methods. forty-four Sprague Dawley rats underwent l
aminectomies and were treated with dexamethasone in one of two control
led-release vehicles or with vehicle alone. After 4 weeks, the rats we
re killed and histologic sections prepared from the spines were examin
ed and graded by a pathologist, In addition, the dexamethasone prepara
tions were introduced into Hunt-Schilling wound chambers, which were i
mplanted in rats. Four weeks after implantation, the wound chambers we
re removed and the tissue inside was assayed for DNA and protein conte
nt. Results, Dexamethasone acetate (Decadron, MSD, West Point, PA) sig
nificantly reduced the density of the scar tissue undermining the lami
nas. Steroids embedded in polymer did not change the scar formation in
the back, but did decrease protein and DNA values in wound chamber ti
ssues, Conclusions, Long-term release of small amounts of steroid from
the polymer poly-carboxy-phenoxy-propane does not appear to reduce sc
ar at laminectomy sites but does decrease the protein:DNA ratio in wou
nd chambers, In contrast, Decadron does not significantly alter the bi
ochemistry of wound chamber tissue but does reduce scar in the back.